Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF‐90‐mediated ribosomal RNA synthesis

The ErbB3‐binding protein 1 (Ebp1) has been reported as either an oncogenic regulator or a tumor suppressor in a variety of cancers. Here, we show that Ebp1 p48, a predominant expression isoform, is highly expressed in the majority of human colon tumor cells compared with normal adjacent tissues and its expression is required for the oncogenic activities of these cells. Depletion of Ebp1 expression in primary colon cancer cells inhibits cell proliferation, colony forming, and invasion in vitro as well as tumor formation in vivo and enhances cell sensitivity to irradiation. We further demonstrated that Ebp1 interacts with TIF‐90, a splice variant of transcription initiation factor IA (TIF‐IA) of the RNA polymerase I complex, allowing for regulation of ribosomal RNA (rRNA) synthesis and oncogenesis in human colon cancer cells. Moreover, Ebp1 expression is essential for Akt protected TIF‐90 stability by preventing TIF‐90's ubiquitination by Mdm2 and hence, its proteasomal degradation. The results of the present study support a mechanism of underlying oncogenic activities by means of Ebp1 through regulation of TIF‐90‐mediated rRNA synthesis and suggest the potential therapeutic treatment of colon cancer by targeting Ebp1 and its signaling.

[1]  L. Ghoda,et al.  The role of ErbB3 binding protein 1 in cancer: Friend or foe? , 2018, Journal of cellular physiology.

[2]  B. Mitchell,et al.  Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells , 2016, Clinical Cancer Research.

[3]  Jee-Yin Ahn,et al.  Phosphorylation of the N‐terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48 , 2015, Molecular carcinogenesis.

[4]  B. Mitchell,et al.  Regulation of Ribosomal Gene Expression in Cancer , 2015, Journal of cellular physiology.

[5]  B. Mitchell,et al.  Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1. , 2015, Blood.

[6]  R. Majeti,et al.  Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells. , 2014, Blood.

[7]  B. Mitchell,et al.  Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA , 2013, Proceedings of the National Academy of Sciences.

[8]  D. Nam,et al.  Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors. , 2010, Cancer research.

[9]  D. Brat,et al.  Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. , 2008, Molecular biology of the cell.

[10]  Zhenqiu Liu,et al.  Bmc Cell Biology Alterations in Cell Growth and Signaling in Erbb3 Binding Protein-1 (ebp1) Deficient Mice , 2022 .

[11]  S. Curry,et al.  Structural insights into the transcriptional and translational roles of Ebp1 , 2007, The EMBO journal.

[12]  T. D. de Gruijl,et al.  Identification and Characterization of ErbB-3-Binding Protein-1 as a Target for Immunotherapy1 , 2007, The Journal of Immunology.

[13]  Rik,et al.  Identification and Characterization of ErbB-3-Binding Protein-1 as a Target for Immunotherapy , 2007 .

[14]  Jee-Yin Ahn,et al.  Ebp1 isoforms distinctively regulate cell survival and differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Jee-Yin Ahn,et al.  Nuclear Akt associates with PKC‐phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase‐activated DNase , 2006, The EMBO journal.